Acetylcholinesterase/Butyrylcholinesterase inhibition activity of some new carbacylamidophosphate deriviatives

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 24, Issue 2, 2009, Pages 566-576

  Gholivand, Khodayar ^a   Abdollahi, Mohammad ^b   Mojahed, Fresia ^a   Alizadehgan, Ahlam Madani ^a   Dehghan, Gholamreza ^b  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Acetylcholinesterase; Butyrylcholinesterase IC50; Carbacylamidophosphates; KD; Ki; Kp

Indexed keywords

ACETYLCHOLINESTERASE; CARBACYLAMIDOPHOSPHATE DERIVATIVE; CHOLINESTERASE; PHOSPHORAMIDIC ACID DERIVATIVE; UNCLASSIFIED DRUG; AMIDE; CHOLINESTERASE INHIBITOR; PHOSPHORAMIDIC ACID; PHOSPHORIC ACID;

ARTICLE; CHOLINESTERASE INHIBITION; HUMAN; IC 50; INHIBITION KINETICS; NONHUMAN; PARAMETER; PRIORITY JOURNAL; ANIMAL; CATTLE; CHEMISTRY; KINETICS; METABOLISM; MOUSE; MOUSE STRAIN;

BOVINAE;

ACETYLCHOLINESTERASE; AMIDES; ANIMALS; BUTYRYLCHOLINESTERASE; CATTLE; CHOLINESTERASE INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; KINETICS; MICE; MICE, INBRED STRAINS; PHOSPHORIC ACIDS;

EID: 68049114615     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360802316971     Document Type: Article

References (32)

1. Augustinsson KB. Acta Physiol Scand 1948;15:1.
2. Wilson IB, Pauling L, Itano H, editors. Acetylcholinesterase: molecular structure and biological specificity. New York, USA: American Institute of Biological Sciences; 1951. p 175-185.
3. Cokugras AN, Teczan F. Gen Pharmacol 1997;29:835.
4. Karczmar A. Neurochem Int 1998;32:401.
5. Massoulié J, Pezzementi L, Bom S, Krejci E. Prog Neurobiol 1993;41:31.
6. Hijikata-Okunomiya A, Okamoto S, Tamao Y, Kikumoto R. J Biol Chem 1988;23:269.
7. Lockridge O. BioEssays 1988;9:125.
8. Gómez-Ramos P, Morán MA. Mol Chem Neuropathol 1997; 30:161.
9. Milatovic D, Dettbarn WD. Toxicol Appl Pharmacol 1996; 136:20.
10. Schetinger MRC, Porto NM, Moretto MB, Morsch VM, Rocha JBT, Vieira V, Moro F, Neis RT, Bittencourt S, Bonacorso HG, Zanatta N. Neurochem Res 2000;25:949.
11. Benzi G, Moretti A. Eur J Pharmacol 1998;346:1.
12. Nitsch RM, Slack BE, Wurtman RJ, Growdon JH. Science 1992;258:304.
13. Szegletes T, Mallander WD, Thomas PJ, Rosenberry TL. Biochemistry 1999;38:122.
14. Harel M, Schalk I, Ehret-Sabatier L, Bouet F, Goeldner M, Axelsen CP, Silman I, Sussman JL. Proc Natl Acad Sci USA 1993;90:9031.
15. Ekholm M. J Mol Struct 2001;572:25.
16. Gholivand K, Madani Alizadehgan A, Anaraki Firooz A, Khajeh K, Naderi-manesh H, Bijanzadeh H. J Enz Inhib Med Chem 2006;21:105.
17. Gholivand K, Mojahed F, Salehi M, Naderi-manesh H, Khajeh K. J Enz Inhib Med Chem 2006;21:521.
18. Gholivand K, Mojahed F, Alizadehgan AM, Bijanzadeh HR. Zeitschrift für anorganische und allgemeine Chemie 2006; 632:1570.
19. Gholivand K, Mojahed F, Alizadehgan AM. J Chem 2007;81: 393.
20. Kitz R, Wilson IB. J Biol Chem 1962;237:3245.
21. Segel IH, New York: Wiley; 1975.
22. Doorn JA, Gage DA, Schall M, Talley TT, Thompson CM, Richardson R. J Chem Res Toxicol 2000;13:1313.
23. Barak D, Ordentlich A, Kaplan D, Barak R, Mizrahi D, Kronman C, Segall Y, Velan B, Shafferman A. Biochemistry 2000;39:1156.
24. Tompson CM, Suarez AI, Rodriguez OP. Chem Res Toxicol 1996;9:1325.
25. Corbridge DEC. Phosphorus, an outline of its chemistry, biochemistry and technology. Fifth Edition The Netherlands: Elsevier; 1995.
26. Janice E, Seth F. Toxicol Sci 2004;77:185.
27. Ellman GL, Courinfy KD, Andress V, Featherstone RM. Biochem Pharmacol 1961;7:88.
28. Schultz TW, Cronin MTD, Walker JD, Aptula AO. J Mol Struct (Theochem) 2003;622:1.
29. Karelson M, Lobanov VS, Katritzky AR. Chem Rev 1996;96: 1027.
30. Lewis DFV. Toxicol 2004;18:89, in Vitro.
31. Hansch C, Steinmetz WE, Leo AJ, Mekapati SB, Kurup A, Hoekman D. Inf Comput Sci 2003;43:120.
32. Hansch C, Dunn W. J Pharm Sci-Us 1972;61:1.